Search Results - "Groen, Albert K."

Refine Results
  1. 1

    The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism by den Besten, Gijs, van Eunen, Karen, Groen, Albert K., Venema, Koen, Reijngoud, Dirk-Jan, Bakker, Barbara M.

    Published in Journal of lipid research (01-09-2013)
    “…Short-chain fatty acids (SCFAs), the end products of fermentation of dietary fibers by the anaerobic intestinal microbiota, have been shown to exert multiple…”
    Get full text
    Journal Article
  2. 2

    Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction by Bouter, Kristien E, van Raalte, Daniël H, Groen, Albert K, Nieuwdorp, Max

    Published in Gastroenterology (New York, N.Y. 1943) (01-05-2017)
    “…The potential role of intestinal microbiota in the etiology of various human diseases has attracted massive attention in the last decade. As such, the…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy by van Stee, Mariël F, de Graaf, Albert A, Groen, Albert K

    Published in Cardiovascular diabetology (30-06-2018)
    “…Patients with diabetes type 2 have an increased risk for cardiovascular disease and commonly use combination therapy consisting of the anti-diabetic drug…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Zonation of glucose and fatty acid metabolism in the liver: Mechanism and metabolic consequences by Hijmans, Brenda S., Grefhorst, Aldo, Oosterveer, Maaike H., Groen, Albert K.

    Published in Biochimie (01-01-2014)
    “…The liver is generally considered as a relatively homogeneous organ containing four different cell types. It is however well-known that the liver is not…”
    Get full text
    Journal Article
  12. 12

    Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice by Schonewille, Marleen, Freark de Boer, Jan, Mele, Laura, Wolters, Henk, Bloks, Vincent W., Wolters, Justina C., Kuivenhoven, Jan A., Tietge, Uwe J.F., Brufau, Gemma, Groen, Albert K.

    Published in Journal of lipid research (01-08-2016)
    “…Statins are competitive inhibitors of HMG-CoA reductase, the rate-limiting enzyme of cholesterol synthesis. Statins reduce plasma cholesterol levels, but…”
    Get full text
    Journal Article
  13. 13

    Role of Intestinal Microbiome in Lipid and Glucose Metabolism in Diabetes Mellitus by van Olden, Casper, Msc, Groen, Albert K., PhD, Nieuwdorp, Max, MD, PhD

    Published in Clinical therapeutics (01-06-2015)
    “…Abstract Purpose The contribution of intestinal bacterial strains (gut microbiota) in human metabolism and obesity is being increasingly recognized. The goal…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Transintestinal cholesterol excretion in humans by Reeskamp, Laurens F, Meessen, Emma C E, Groen, Albert K

    Published in Current opinion in lipidology (01-02-2018)
    “…To discuss recent insights into the measurement and cellular basis of transintestinal cholesterol excretion (TICE) in humans and to explore TICE as a…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk by Koopen, Annefleur M., Groen, Albert K., Nieuwdorp, Max

    Published in Current opinion in lipidology (01-12-2016)
    “…The absolute burden of cardiovascular risk remains high despite currently available preventive and therapeutic options. In search for novel therapeutic leads,…”
    Get full text
    Journal Article
  19. 19

    An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases by Groen, Albert K, Nieuwdorp, Max

    Published in EMBO molecular medicine (01-01-2017)
    “…Fecal microbiota transplantation (FMT) has had a long history in medicine for treating a number of human diseases. As early as during the 4 th century BC, FMT…”
    Get full text
    Journal Article
  20. 20

    Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1 by Kaur, Achint, Patankar, Jay V, de Haan, Willeke, Ruddle, Piers, Wijesekara, Nadeeja, Groen, Albert K, Verchere, C Bruce, Singaraja, Roshni R, Hayden, Michael R

    Published in Diabetes (New York, N.Y.) (01-04-2015)
    “…Besides their role in facilitating lipid absorption, bile acids are increasingly being recognized as signaling molecules that activate cell-signaling…”
    Get full text
    Journal Article